Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Texas Oncology
InstitutionResearch output, impact & collaborations
Texas Oncology is a research organisation in Oklahoma City, US. OpenAlex records 4,962 works and 661,816 citations for it. 1,091 researchers list it as their most recent affiliation.
4,962
Works
661,816
Citations
1,091
Researchers
65.2
Avg h-index
How has Texas Oncology's publication output changed over time?
ScholarIQpublication output · 2007–2023
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2023.
1
1
1
2
1
1
1
1
1
1
2007201020122016201720182019202020212023
Who are the most-cited researchers behind Texas Oncology?
ScholarIQtop researchers by citations
What are the most-cited papers on Texas Oncology?
ScholarIQmost cited works
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Pedro T. Ramírez, Michael Frumovitz, René Pareja, Aldo López, Marcelo de Andrade Vieira, Reitan Ribeiro, Alessandro Buda, Xiaojian Yan, Yao Shuzhong, Naven Chetty, David Isla, Mariano Tamura, Tao Zhu, Kristy Robledo, Val Gebski, Rebecca Asher, Vanessa Behan, James Nicklin, Robert L. Coleman, Andreas Obermair
New England Journal of Medicine. 20181,885 CitationsOPEN ACCESS
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly, Jaffer A. Ajani, Jarosław Kużdżał, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Méndez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope E. Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H. Ko, Kynan Feeney, Michael Schenker, Piotr Kocoń, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M. Cleary, Markus Moehler
New England Journal of Medicine. 20211,813 CitationsOPEN ACCESS
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith, Marion Procter, Richard D. Gelber, Sébastien Guillaume, A. Feyereislova, Mitch Dowsett, Aron Goldhirsch, Michael Untch, Gabriella Mariani, José Baselga, Manfred Kaufmann, David Cameron, Richard H. Bell, Jonas Bergh, Robert L. Coleman, Andrew Wardley, Nadia Harbeck, R.I. Lopez, Peter Mallmann, Karen A. Gelmon, Nicholas Wilcken, Erik Wist, Pedro Sánchez‐Rovira, Martine Piccart
The Lancet. 20071,514 Citations
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Jesusa M.G. Arevalo, Rie Takahashi, Chunhua Lu, Nicholas B. Jennings, Guillermo N. Armaiz-Peña, James A. Bankson, Murali Ravoori, William M. Merritt, Yvonne G. Lin, Lingegowda S. Mangala, Tae Jin Kim, Robert L. Coleman, Charles N. Landen, Yang Li, Edward Felix, Ángela Sanguino, Robert A. Newman, Mary Lloyd, David M. Gershenson, Vikas Kundra, Gabriel Lopez‐Berestein, Susan K. Lutgendorf, Steve W. Cole, Anil K. Sood
Nature Medicine. 20061,311 Citations
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher, Kevin Lin, Amit M. Oza, Clare L. Scott, Heidi Giordano, James Sun, Gottfried E. Konecny, Robert L. Coleman, Anna V. Tinker, David M. O’Malley, Rebecca Kristeleit, Ling Ma, Katherine M. Bell‐McGuinn, James D. Brenton, Janiel M. Cragun, Ana Oaknin, Isabelle Ray‐Coquard, Maria I. Harrell, Elaina Mann, Scott H. Kaufmann, Anne Floquet, Alexandra Léary, Thomas C. Harding, Sandra Goble, Lara Maloney, Jeff Isaacson, Andrew R. Allen, Lindsey Rolfe, Roman Yelensky, Mitch Raponi, Iain A. McNeish
The Lancet Oncology. 20161,209 CitationsOPEN ACCESS
How much of the research on Texas Oncology is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
33%
Closed
33%